Smith Group Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Smith Group Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Sell	3,600 -10,250	-74%	-$589K	0.01%	165
2026 Q1	$840K	Buy	+13,850	New	+$807K	0.04%	99
2020 Q4	–	Sell	-323,739	Closed	-$19.5M	–	313
2020 Q3	$19.5M	Sell	323,739 -240,591	-43%	-$14.5M	1.02%	33
2020 Q2	$33.2M	Sell	564,330 -236,650	-30%	-$14.2M	1.83%	14
2020 Q1	$44.7M	Sell	800,980 -79,162	-9%	-$4.84M	2.44%	8
2019 Q4	$56.5M	Sell	880,142 -298,401	-25%	-$17.1M	2.37%	8
2019 Q3	$59.8M	Sell	1,178,543 -18,601	-2%	-$874K	2.1%	9
2019 Q2	$54.3M	Sell	1,197,144 -48,542	-4%	-$2.26M	1.82%	13
2019 Q1	$59.4M	Sell	1,245,686 -5,251	-0.4%	-$262K	1.93%	14
2018 Q4	$65M	Buy	1,250,937 +572,380	+84%	+$30.8M	2.29%	9
2018 Q3	$42.1M	Buy	+678,557	New	+$40.3M	1.2%	28
2016 Q3	–	Sell	-990,710	Closed	-$72.9M	–	455
2016 Q2	$72.9M	Buy	990,710 +807,050	+439%	+$57M	2.18%	9
2016 Q1	$11.7M	Buy	183,660 +18,080	+11%	+$1.14M	0.35%	82
2015 Q4	$11.4M	Buy	+165,580	New	+$10.9M	0.34%	81

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Smith Group Asset Management's BMY Position: Q2 2026 in Review

Smith Group Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 74% in Q2 2026, selling an estimated $589K and leaving 3,600 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #165.

Smith Group Asset Management first reported a position in BMY in Q4 2015 and has held it in 14 quarters since. The position peaked at $72.9M in Q2 2016. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Smith Group Asset Management held 3,600 shares of Bristol-Myers Squibb worth $207K as of Q2 2026.
Smith Group Asset Management sold 10,250 Bristol-Myers Squibb shares in Q2 2026, an estimated $589K.
Bristol-Myers Squibb made up 0.01% of Smith Group Asset Management's portfolio in Q2 2026, its #165 holding.
Smith Group Asset Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 14 quarters since.
Smith Group Asset Management's Bristol-Myers Squibb position peaked at $72.9M in Q2 2016.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.